Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis

Supportive Care in Cancer

Volumn 23, Issue 10, 2015, Pages 2863-2872

  Wu, Chun Wei ^a   Wu, Jiunn Yih ^a   Chen, Chun Kuei ^a   Huang, Shiau Ling ^a   Hsu, Shou Chien ^a   Lee, Meng tse Gabriel ^b   Chang, Shy Shin ^a   Lee, Chien Chang ^b,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Neutropenic fever; Procalcitonin; Sepsis; Serious bacterial infection

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; IL6 PROTEIN, HUMAN; PROTEIN PRECURSOR;

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; EMBASE; FEBRILE NEUTROPENIA; HUMAN; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SYSTEMATIC REVIEW; BLOOD; IMMUNOLOGY; METABOLISM;

BACTERIAL INFECTIONS; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEBRILE NEUTROPENIA; HUMANS; INTERLEUKIN-6; PROTEIN PRECURSORS;

EID: 84940460707     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2650-8     Document Type: Article

References (44)

1. Smith TJ, Khatcheressian J, Lyman GH et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24(19):3187–3205
2. Kuderer NM, Dale DC, Crawford J, Lyman GH (2007) Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25(21):3158–3167
3. de Naurois J, Novitzky-Basso I, Gill MJ, Marti FM, Cullen MH, Roila F (2010) Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 21(Suppl 5):v252–v256
4. Aapro MS, Cameron DA, Pettengell R et al (2006) EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 42(15):2433–2453
5. Malik I, Hussain M, Yousuf H (2001) Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies. J Infect 42(2):120–125
6. Haeusler GM, Carlesse F, Phillips RS (2013) An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer. Pediatr Infect Dis J
7. Lin SG, Hou TY, Huang DH et al (2012) Role of procalcitonin in the diagnosis of severe infection in pediatric patients with fever and Neutropenia—a systemic review and meta-analysis. Pediatr Infect Dis J 31(10):e182–e188
8. Phillips RS, Wade R, Lehrnbecher T, Stewart LA, Sutton AJ (2012) Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med 10:6
9. Bayer L, Schontube M, Dorffel W (2000) C-reactive protein, Il-6 and procalcitonin as infection parameters in children with oncologic diseases. Klin Padiatr 212(6):326–331
10. Bele N (2008) Procalcitonin for the diagnosis of sepsis in critically ill patients, focus on immunocompromised patients. Reanimation (2008) 3(SUPPL 1):5–8
11. Bernard L, Ferriere F, Casassus P et al (1998) Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 27(4):914–915
12. Chawes BL, Rechnitzer C, Schmiegelow K, Tvede M (2007) Procalcitonin for early diagnosis of bacteraemia in children with cancer. Ugeskr Laeger 169(2):138–142
13. de Bont ES, Vellenga E, Swaanenburg J, Kamps W (2000) Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever? Infection 28(6):398–400
14. Eduardo A-O, Marina S-Y, Pablo L-A et al (2010) Valor diagnóstico de la procalcitonina, la interleucina 8, la interleucina 6 y la proteÍna C reactiva en la detección de bacteriemia y fungemia en pacientes con cáncer. Enferm Infecc Microbiol Clin 28(5):273–277
15. Engel A, Steinbach G, Kern P, Kern WV (1999) Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 31(2):185–189
16. Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H (2001) Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 32(12):1718–1725
17. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P et al (2004) Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 10(7):628–633
18. Hitoglou-Hatzi S, Hatzistilianou M, Gougoustamou D et al (2005) Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia. Clin Exp Med 5(2):60–65
19. Jimeno A, Garcia-Velasco A, del Val O et al (2004) Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 100(11):2462–2469
20. Kitanovski L, Jazbec J, Hojker S, Gubina M, Derganc M (2006) Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis 25(6):413–415
21. Lestin F, Lestin H, Burstein C, Anders O, Freund M (1998) Provisional experience with procalcitonin, C-reactive protein, neopterin, selected cytokines, and hemostatic parameters in patients with malignant hematological diseases and febrile neutropenia induced by cytostatic treatment. Clin Lab 44:451–461
22. Martinez-Albarran M, Perez-Molina Jde J, Gallegos-Castorena S et al (2009) Procalcitonin and C-reactive protein serum levels as markers of infection in a pediatric population with febrile neutropenia and cancer. Pediatr Hematol Oncol 26(6):414–425
23. Massaro KS, Costa SF, Leone C, Chamone DA (2007) Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis 7:137
24. Miedema KG, de Bont ES, Elferink RF, et al (2010) The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer
25. Penel N, Fournier C, Degardin M, Kouto H, N’Guyen M (2001) Fever and solid tumor: diagnostic value of procalcitonin and C-reactive protein. Rev Med Interne 22(8):706–714
26. Persson L, Engervall P, Magnuson A et al (2004) Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 36(5):365–371
27. Prat C, Sancho JM, Dominguez J et al (2008) Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 49(9):1752–1761
28. Robinson JO, Lamoth F, Bally F, Knaup M, Calandra T, Marchetti O (2011) Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever? PLoS One 6(4):e18886
29. Ruokonen E, Nousiainen T, Pulkki K, Takala J (1999) Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 18(4):283–285
30. Sandri MT, Passerini R, Leon ME et al (2008) Procalcitonin as a useful marker of infection in hemato-oncological patients with fever. Anticancer Res 28(5B):3061–3065
31. Santolaya ME, Alvarez AM, Aviles CL et al (2008) Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial. Pediatr Infect Dis J 27(6):538–543
32. Sauer M, Tiede K, Fuchs D, Gruhn B, Berger D, Zintl F (2003) Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant 31(12):1137–1142
33. Schmidt N, Palma J, King A, Santolaya ME (2007) C reactive protein and procalcitonin levels for the diagnosis of invasive bacterial infections in allogenic hematopoietic stem cell transplantation recipients. Rev Med Chil 135(8):982–989
34. Secmeer G, Devrim I, Kara A et al (2007) Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol 29(2):107–111
35. Semeraro M, Thomee C, Rolland E et al (2010) A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. Pediatr Blood Cancer 54(2):284–290
36. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A et al (2004) Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 23(7):539–544
37. Higgins J, Green S, eds. (2008) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. London: The Cochrane Collaboration
38. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
39. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25
40. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
41. Galbraith R (1988) Graphical display of estimates having differing standard errors. Technometrics 30(3):271–281
42. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA (2007) Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50(1):34–41
43. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165–228
44. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39(2):206–217